Oppenheimer & Co’s Omega Healthcare OHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.59M | Buy |
59,130
+5,938
| +11% | +$271K | 0.03% | 509 |
|
|
2025
Q4 | $2.36M | Sell |
53,192
-3,253
| -6% | -$140K | 0.03% | 497 |
|
|
2025
Q3 | $2.38M | Buy |
56,445
+1,785
| +3% | +$72K | 0.03% | 545 |
|
|
2025
Q2 | $2M | Buy |
54,660
+8,309
| +18% | +$309K | 0.03% | 574 |
|
|
2025
Q1 | $1.77M | Sell |
46,351
-10,061
| -18% | -$374K | 0.03% | 579 |
|
|
2024
Q4 | $2.14M | Buy |
56,412
+6,699
| +13% | +$268K | 0.03% | 526 |
|
|
2024
Q3 | $2.02M | Sell |
49,713
-1,528
| -3% | -$57.8K | 0.03% | 551 |
|
|
2024
Q2 | $1.76M | Sell |
51,241
-1,219
| -2% | -$38.4K | 0.03% | 575 |
|
|
2024
Q1 | $1.66M | Sell |
52,460
-722
| -1% | -$21.9K | 0.03% | 568 |
|
|
2023
Q4 | $1.63M | Sell |
53,182
-550
| -1% | -$17.6K | 0.03% | 558 |
|
|
2023
Q3 | $1.78M | Hold |
53,732
| – | – | 0.04% | 498 |
|
|
2023
Q2 | $1.65M | Buy |
53,732
+2,469
| +5% | +$71.3K | 0.03% | 524 |
|
|
2023
Q1 | $1.41M | Sell |
51,263
-967
| -2% | -$26.9K | 0.03% | 566 |
|
|
2022
Q4 | $1.46M | Sell |
52,230
-700
| -1% | -$21.1K | 0.03% | 530 |
|
|
2022
Q3 | $1.56M | Sell |
52,930
-25,480
| -32% | -$799K | 0.04% | 505 |
|
|
2022
Q2 | $2.21M | Buy |
78,410
+28,925
| +58% | +$823K | 0.05% | 434 |
|
|
2022
Q1 | $1.54M | Buy |
49,485
+10,809
| +28% | +$319K | 0.03% | 581 |
|
|
2021
Q4 | $1.14M | Buy |
38,676
+5,519
| +17% | +$161K | 0.02% | 729 |
|
|
2021
Q3 | $993K | Sell |
33,157
-15,223
| -31% | -$524K | 0.02% | 740 |
|
|
2021
Q2 | $1.76M | Buy |
48,380
+17,030
| +54% | +$632K | 0.03% | 558 |
|
|
2021
Q1 | $1.15M | Hold |
31,350
| – | – | 0.02% | 660 |
|
|
2020
Q4 | $1.14M | Buy |
31,350
+2,000
| +7% | +$67.8K | 0.02% | 602 |
|
|
2020
Q3 | $879K | Buy |
29,350
+500
| +2% | +$15.6K | 0.02% | 634 |
|
|
2020
Q2 | $858K | Sell |
28,850
-2,595
| -8% | -$76.9K | 0.02% | 632 |
|
|
2020
Q1 | $835K | Buy |
31,445
+10,845
| +53% | +$411K | 0.03% | 583 |
|
|
2019
Q4 | $872K | Hold |
20,600
| – | – | 0.02% | 666 |
|
|
2019
Q3 | $861K | Buy |
20,600
+2,000
| +11% | +$77.9K | 0.02% | 635 |
|
|
2019
Q2 | $684K | Sell |
18,600
-1,100
| -6% | -$40.1K | 0.02% | 711 |
|
|
2019
Q1 | $752K | Buy |
19,700
+100
| +0.5% | +$3.71K | 0.02% | 673 |
|
|
2018
Q4 | $689K | Sell |
19,600
-291
| -1% | -$10.1K | 0.02% | 636 |
|
|
2018
Q3 | $652K | Buy |
19,891
+2,490
| +14% | +$79.3K | 0.02% | 755 |
|
|
2018
Q2 | $539K | Buy |
17,401
+9,772
| +128% | +$279K | 0.01% | 833 |
|
|
2018
Q1 | $206K | Buy |
+7,629
| New | +$203K | 0.01% | 1206 |
|
Other funds holding OHI
VPM
VCM
Oppenheimer & Co's OHI Position: Q1 2026 in Review
Oppenheimer & Co increased its Omega Healthcare (OHI) stake by 11% in Q1 2026, buying an estimated $271K and bringing the position to 59,130 shares worth $2.59M. The position accounts for 0.03% of the portfolio, ranked #509.
Oppenheimer & Co first reported a position in OHI in Q1 2018 and has held it in 33 quarters since. 743 funds tracked by Wall St. Rank hold OHI as of Q1 2026.
- Oppenheimer & Co held 59,130 shares of Omega Healthcare worth $2.59M as of Q1 2026.
- Oppenheimer & Co bought 5,938 Omega Healthcare shares in Q1 2026, an estimated $271K.
- Omega Healthcare made up 0.03% of Oppenheimer & Co's portfolio in Q1 2026, its #509 holding.
- Oppenheimer & Co first reported a position in Omega Healthcare in Q1 2018 and has held it in 33 quarters since.
- 743 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.
Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.